High-Quality laser therapy device pldd - Company

Data Dimension: Adoption Trend by Device Technology Over Time

Adoption Trend of Laser Therapy Technologies (2017-2024)

Explanation and key insights: This chart shows how adoption rates for three laser therapy modalities evolve from 2017 to 2024. The Nd:YAG Pulsed line begins highest, reflecting long-standing clinical use for a range of procedures. Its growth is steady but moderate, suggesting continued relevance but slower rate of change as newer technologies appear. The CO2 Fractional line starts lower but expands rapidly in the later years, illustrating the surge in fractional resurfacing demand driven by improved safety profiles, shorter downtimes, and broader indication sets in dermatology and aesthetic medicine. The Er:YAG Fractional line remains the lowest in early years, yet demonstrates the strongest relative growth, signaling fast uptake of higher-precision micro-ablation benefits and refined control of tissue depth. By 2023–2024, the Er:YAG line closes the gap with the others, while CO2 remains competitive. This convergence implies a market transition from traditional, non-fractional therapies to more advanced fractional and hybrid devices, as clinicians seek superior skin remodeling, scar revision, and wrinkle reduction with acceptable recovery periods. The data dimension represented here is adoption rate as a percentage of the total market share for each technology, normalized across years to enable meaningful comparison. The horizontal axis denotes time in years, and the vertical axis denotes adoption percentage. The three colored lines correspond to Nd:YAG Pulsed (blue), CO2 Fractional (green), and Er:YAG Fractional (orange). In practice, medical device manufacturers and clinics use these trends to guide investment in R&D, regulatory strategy, and training programs, as well as to refine product messaging around energy control, safety features, and versatility. While the numbers in this chart are illustrative, they reflect typical lifecycle dynamics: established incumbents provide steady value, while fractional platforms capture accelerating demand as clinicians adopt more precise, safer, and patient-friendly options. The visual emphasizes the importance of technology maturity and evidence in shaping future market leadership.